Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Explore clinical trials studying Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer trial results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Completed

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

NCT02333370

Conditions
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Locations
  • Novartis Investigative Site Hong Kong
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
  • Novartis Investigative Site Yokohama, Kanagawa, Japan
View all 15 locations
View Trial Details

Related conditions